Biocept Ownership 2024 | Who Owns Biocept Now?
Institutional Ownership
0.36%
Insider Ownership
9.21%
Retail Ownership
90.43%
Institutional Holders
17.00
Biocept Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | 1.14% | 0.00% | 193,741 | 31,441 | 19.37% | 66,000 | Mar 31, 2023 |
BLACKROCK INC. | 0.93% | - | 157,913 | - | - | 53,690,000 | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | 0.79% | - | 134,112 | -3,386 | -2.46% | 45,598,000 | Mar 31, 2023 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.56% | 0.00% | 94,200 | -15,236 | -13.92% | 32,028,000 | Mar 31, 2023 |
HRT FINANCIAL LP | 0.33% | 0.00% | 55,334 | 55,334 | 100.00% | 18,000 | Mar 31, 2023 |
STATE STREET CORP | 0.24% | - | 40,596 | - | - | 13,803,000 | Mar 31, 2023 |
SABBY MANAGEMENT, LLC | 0.17% | 0.01% | 29,602 | -900 | -2.95% | 10,065,000 | Mar 31, 2023 |
NORTHERN TRUST CORP | 0.16% | - | 26,818 | - | - | 9,118,000 | Mar 31, 2023 |
TAYLOR & MORGAN WEALTH MANAGEMENT, LLC | 0.15% | 0.01% | 26,000 | - | - | 8,840,000 | Mar 31, 2023 |
JANE STREET GROUP, LLC | 0.15% | - | 25,403 | 25,403 | 100.00% | 8,637,000 | Mar 31, 2023 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.13% | - | 22,477 | 10,331 | 85.06% | 7,642,000 | Mar 31, 2023 |
ERGOTELES LLC | 0.13% | 0.00% | 22,020 | 22,020 | 100.00% | 7,487,000 | Mar 31, 2023 |
ACADIAN ASSET MANAGEMENT LLC | 0.08% | - | 13,871 | - | - | 4,000 | Mar 31, 2023 |
AMERIPRISE FINANCIAL INC | 0.07% | - | 11,602 | -673 | -5.48% | 3,945,000 | Mar 31, 2023 |
GOLDMAN SACHS GROUP INC | 0.06% | - | 10,903 | 10,903 | 100.00% | 3,707,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.05% | 0.00% | 8,369 | -17 | -0.20% | 3,000 | Mar 31, 2023 |
CITADEL ADVISORS LLC | 0.05% | - | 8,209 | -2,187 | -21.04% | 2,791,000 | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | 0.05% | - | 8,000 | 7,190 | 887.65% | 2,720,000 | Mar 31, 2023 |
CITADEL ADVISORS LLC | 0.03% | - | 4,800 | -34,600 | -87.82% | 1,632,000 | Mar 31, 2023 |
UBS GROUP AG | 0.03% | - | 4,412 | -3,815 | -46.37% | 1,500,000 | Mar 31, 2023 |
Biocept's largest institutional shareholder is RENAISSANCE TECHNOLOGIES LLC, holding 1.14% of the company's total share outstanding, currently valued at $66.00K. The top 10 institutional shareholders own together 4.62% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SABBY MANAGEMENT, LLC | 0.17% | 0.01% | 29,602 | -900 | -2.95% | 10,065,000 | Mar 31, 2023 |
TAYLOR & MORGAN WEALTH MANAGEMENT, LLC | 0.15% | 0.01% | 26,000 | - | - | 8,840,000 | Mar 31, 2023 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.56% | 0.00% | 94,200 | -15,236 | -13.92% | 32,028,000 | Mar 31, 2023 |
ERGOTELES LLC | 0.13% | 0.00% | 22,020 | 22,020 | 100.00% | 7,487,000 | Mar 31, 2023 |
HRT FINANCIAL LP | 0.33% | 0.00% | 55,334 | 55,334 | 100.00% | 18,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.05% | 0.00% | 8,369 | -17 | -0.20% | 3,000 | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | 1.14% | 0.00% | 193,741 | 31,441 | 19.37% | 66,000 | Mar 31, 2023 |
ACADIAN ASSET MANAGEMENT LLC | 0.08% | - | 13,871 | - | - | 4,000 | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | 0.05% | - | 8,000 | 7,190 | 887.65% | 2,720,000 | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | 0.79% | - | 134,112 | -3,386 | -2.46% | 45,598,000 | Mar 31, 2023 |
JANE STREET GROUP, LLC | 0.15% | - | 25,403 | 25,403 | 100.00% | 8,637,000 | Mar 31, 2023 |
NORTHERN TRUST CORP | 0.16% | - | 26,818 | - | - | 9,118,000 | Mar 31, 2023 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.13% | - | 22,477 | 10,331 | 85.06% | 7,642,000 | Mar 31, 2023 |
BLACKROCK INC. | 0.93% | - | 157,913 | - | - | 53,690,000 | Mar 31, 2023 |
AMERIPRISE FINANCIAL INC | 0.07% | - | 11,602 | -673 | -5.48% | 3,945,000 | Mar 31, 2023 |
GOLDMAN SACHS GROUP INC | 0.06% | - | 10,903 | 10,903 | 100.00% | 3,707,000 | Mar 31, 2023 |
STATE STREET CORP | 0.24% | - | 40,596 | - | - | 13,803,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 1,000 | -1,000 | -50.00% | 340,000 | Mar 31, 2023 |
CITADEL ADVISORS LLC | 0.05% | - | 8,209 | -2,187 | -21.04% | 2,791,000 | Mar 31, 2023 |
UBS GROUP AG | 0.03% | - | 4,412 | -3,815 | -46.37% | 1,500,000 | Mar 31, 2023 |
The largest Biocept shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 29.60K shares of Biocept (BIOC), representing 0.01% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
HRT FINANCIAL LP | 0.33% | 0.00% | 55,334 | 55,334 | 100.00% | 18,000 | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | 1.14% | 0.00% | 193,741 | 31,441 | 19.37% | 66,000 | Mar 31, 2023 |
JANE STREET GROUP, LLC | 0.15% | - | 25,403 | 25,403 | 100.00% | 8,637,000 | Mar 31, 2023 |
ERGOTELES LLC | 0.13% | 0.00% | 22,020 | 22,020 | 100.00% | 7,487,000 | Mar 31, 2023 |
GOLDMAN SACHS GROUP INC | 0.06% | - | 10,903 | 10,903 | 100.00% | 3,707,000 | Mar 31, 2023 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.13% | - | 22,477 | 10,331 | 85.06% | 7,642,000 | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | 0.05% | - | 8,000 | 7,190 | 887.65% | 2,720,000 | Mar 31, 2023 |
FMR LLC | 0.00% | - | 20 | 20 | 100.00% | 7,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 118 | 2 | 1.72% | 40,000 | Mar 31, 2023 |
ROYAL BANK OF CANADA | 0.02% | - | 3,487 | - | - | 1,000,000 | Mar 31, 2023 |
US BANCORP \DE\ | 0.00% | - | 583 | - | - | 198,000 | Mar 31, 2023 |
STATE STREET CORP | 0.24% | - | 40,596 | - | - | 13,803,000 | Mar 31, 2023 |
BLACKROCK INC. | 0.93% | - | 157,913 | - | - | 53,690,000 | Mar 31, 2023 |
NORTHERN TRUST CORP | 0.16% | - | 26,818 | - | - | 9,118,000 | Mar 31, 2023 |
ACADIAN ASSET MANAGEMENT LLC | 0.08% | - | 13,871 | - | - | 4,000 | Mar 31, 2023 |
TAYLOR & MORGAN WEALTH MANAGEMENT, LLC | 0.15% | 0.01% | 26,000 | - | - | 8,840,000 | Mar 31, 2023 |
FOCUSED WEALTH MANAGEMENT, INC | - | - | - | -1 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.05% | 0.00% | 8,369 | -17 | -0.20% | 3,000 | Mar 31, 2023 |
CITADEL ADVISORS LLC | 0.00% | - | 100 | -100 | -50.00% | 34,000 | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | - | - | - | -540 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Biocept's largest institutional buyer is HRT FINANCIAL LP. The company purchased 55.33K stocks of BIOC, valued at $18.00K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VANGUARD GROUP INC | - | - | - | -617,984 | -100.00% | - | Mar 31, 2023 |
CITADEL ADVISORS LLC | 0.03% | - | 4,800 | -34,600 | -87.82% | 1,632,000 | Mar 31, 2023 |
VIRTU FINANCIAL LLC | - | - | - | -23,001 | -100.00% | - | Mar 31, 2023 |
SIMPLEX TRADING, LLC | - | - | - | -20,500 | -100.00% | - | Mar 31, 2023 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | - | - | - | -16,200 | -100.00% | - | Mar 31, 2023 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.56% | 0.00% | 94,200 | -15,236 | -13.92% | 32,028,000 | Mar 31, 2023 |
CWM, LLC | - | - | - | -11,200 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | 0.03% | - | 4,412 | -3,815 | -46.37% | 1,500,000 | Mar 31, 2023 |
SIMPLEX TRADING, LLC | - | - | - | -3,768 | -100.00% | - | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | 0.79% | - | 134,112 | -3,386 | -2.46% | 45,598,000 | Mar 31, 2023 |
CITADEL ADVISORS LLC | 0.05% | - | 8,209 | -2,187 | -21.04% | 2,791,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 1,000 | -1,000 | -50.00% | 340,000 | Mar 31, 2023 |
SABBY MANAGEMENT, LLC | 0.17% | 0.01% | 29,602 | -900 | -2.95% | 10,065,000 | Mar 31, 2023 |
AMERIPRISE FINANCIAL INC | 0.07% | - | 11,602 | -673 | -5.48% | 3,945,000 | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | - | - | - | -540 | -100.00% | - | Mar 31, 2023 |
CITADEL ADVISORS LLC | 0.00% | - | 100 | -100 | -50.00% | 34,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.05% | 0.00% | 8,369 | -17 | -0.20% | 3,000 | Mar 31, 2023 |
FOCUSED WEALTH MANAGEMENT, INC | - | - | - | -1 | -100.00% | - | Mar 31, 2023 |
TAYLOR & MORGAN WEALTH MANAGEMENT, LLC | 0.15% | 0.01% | 26,000 | - | - | 8,840,000 | Mar 31, 2023 |
ACADIAN ASSET MANAGEMENT LLC | 0.08% | - | 13,871 | - | - | 4,000 | Mar 31, 2023 |
As of Mar 31 2023, Biocept's biggest institutional seller is VANGUARD GROUP INC. The company sold -0.62M shares of BIOC, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
HRT FINANCIAL LP | 0.33% | 0.00% | 55,334 | 55,334 | 100.00% | 18,000 | Mar 31, 2023 |
JANE STREET GROUP, LLC | 0.15% | - | 25,403 | 25,403 | 100.00% | 8,637,000 | Mar 31, 2023 |
ERGOTELES LLC | 0.13% | 0.00% | 22,020 | 22,020 | 100.00% | 7,487,000 | Mar 31, 2023 |
GOLDMAN SACHS GROUP INC | 0.06% | - | 10,903 | 10,903 | 100.00% | 3,707,000 | Mar 31, 2023 |
FMR LLC | 0.00% | - | 20 | 20 | 100.00% | 7,000 | Mar 31, 2023 |
Biocept's largest new institutional shareholder by number of shares is HRT FINANCIAL LP, purchased 55.33K shares, valued at $18.00K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VANGUARD GROUP INC | - | - | - | -617,984 | -100.00% | - | Mar 31, 2023 |
VIRTU FINANCIAL LLC | - | - | - | -23,001 | -100.00% | - | Mar 31, 2023 |
SIMPLEX TRADING, LLC | - | - | - | -20,500 | -100.00% | - | Mar 31, 2023 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | - | - | - | -16,200 | -100.00% | - | Mar 31, 2023 |
CWM, LLC | - | - | - | -11,200 | -100.00% | - | Mar 31, 2023 |
SIMPLEX TRADING, LLC | - | - | - | -3,768 | -100.00% | - | Mar 31, 2023 |
BANK OF AMERICA CORP /DE/ | - | - | - | -540 | -100.00% | - | Mar 31, 2023 |
FOCUSED WEALTH MANAGEMENT, INC | - | - | - | -1 | -100.00% | - | Mar 31, 2023 |
Biocept's largest sold out institutional shareholder by shares sold is VANGUARD GROUP INC, sold -0.62M shares, valued at -, as of undefined.
Biocept Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
BRIDGEWAY FUNDS INC | 0.04% | 94,200 | - | - | Mar 28, 2024 |
HUSSMAN INVESTMENT TRUST | 0.02% | 72,000 | - | - | Dec 31, 2023 |
VANGUARD INDEX FUNDS | 0.02% | 6,422,826 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 801,006 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 612,643 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 129,601 | - | - | Feb 29, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 8,656 | - | - | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 22,043 | - | - | Jan 31, 2024 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 9,325 | - | - | Jan 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 4,273 | - | - | Feb 29, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 18,363 | - | - | Jan 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 4,434 | - | - | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 1,920 | - | - | Jan 31, 2024 |
Dimensional ETF Trust | 0.00% | 2,200 | - | - | Jan 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 2,888 | - | - | Mar 31, 2024 |
Biocept's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 94.20K shares, compromising 0.04% of its total assets.
Biocept Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 20 | 17 | 13.33% |
31 Mar, 20 | 15 | 15.38% |
31 Dec, 19 | 13 | 18.18% |
30 Sep, 19 | 11 | 10.00% |
30 Jun, 19 | 10 | -37.50% |
31 Mar, 19 | 16 | 45.45% |
31 Dec, 18 | 11 | 57.14% |
30 Sep, 18 | 7 | 250.00% |
30 Jun, 18 | 2 | - |
As of 30 Jun 20, 17 institutions are holding Biocept's shares, representing an increase of 13.33% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 20 | 13,704,608 | 342.00% |
31 Mar, 20 | 3,100,601 | 201.37% |
31 Dec, 19 | 1,028,825 | 177.30% |
30 Sep, 19 | 371,013 | 1.49% |
30 Jun, 19 | 365,572 | -17.32% |
31 Mar, 19 | 442,130 | 33.13% |
31 Dec, 18 | 332,114 | 40.03% |
30 Sep, 18 | 237,168 | -0.46% |
30 Jun, 18 | 238,268 | - |
Biocept (BIOC) has 13.70M shares outstanding as of 30 Jun 20, up 342.00% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 20 | 0.36% | 2099.16% |
31 Mar, 20 | 0.13% | 6944.01% |
31 Dec, 19 | 0.04% | 17662.42% |
30 Sep, 19 | 0.02% | 6590.26% |
30 Jun, 19 | 0.02% | 4421.39% |
31 Mar, 19 | 0.02% | 9509.29% |
31 Dec, 18 | 0.01% | 14003.00% |
30 Sep, 18 | 0.01% | 9953833.33% |
30 Jun, 18 | 0.00% | - |
As of 30 Jun 20, Biocept is held by 0.36% institutional shareholders, representing a 2099.16% growth compared to 31 Mar 20.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 20 | 13 | 18.18% |
31 Mar, 20 | 11 | 22.22% |
31 Dec, 19 | 9 | 125.00% |
30 Sep, 19 | 4 | 33.33% |
30 Jun, 19 | 3 | -76.92% |
31 Mar, 19 | 13 | 62.50% |
31 Dec, 18 | 8 | 14.29% |
30 Sep, 18 | 7 | 250.00% |
30 Jun, 18 | 2 | - |
13 institutional shareholders have increased their position in BIOC stock as of 30 Jun 20 compared to 11 in the previous quarter (a 18.18% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 20 | 1 | - |
31 Mar, 20 | 1 | - |
31 Dec, 19 | - | -100.00% |
30 Sep, 19 | 1 | - |
30 Jun, 19 | 1 | - |
31 Mar, 19 | 1 | -50.00% |
31 Dec, 18 | 2 | - |
30 Sep, 18 | - | - |
30 Jun, 18 | - | - |
1 institutional shareholders have reduced their position in BIOC stock as of 30 Jun 20 compared to 1 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 20 | 17 | 13.33% | 13,704,608 | 342.00% | 0.36% | 2099.16% | 13 | 18.18% | 1 | - |
31 Mar, 20 | 15 | 15.38% | 3,100,601 | 201.37% | 0.13% | 6944.01% | 11 | 22.22% | 1 | - |
31 Dec, 19 | 13 | 18.18% | 1,028,825 | 177.30% | 0.04% | 17662.42% | 9 | 125.00% | - | -100.00% |
30 Sep, 19 | 11 | 10.00% | 371,013 | 1.49% | 0.02% | 6590.26% | 4 | 33.33% | 1 | - |
30 Jun, 19 | 10 | -37.50% | 365,572 | -17.32% | 0.02% | 4421.39% | 3 | -76.92% | 1 | - |
31 Mar, 19 | 16 | 45.45% | 442,130 | 33.13% | 0.02% | 9509.29% | 13 | 62.50% | 1 | -50.00% |
31 Dec, 18 | 11 | 57.14% | 332,114 | 40.03% | 0.01% | 14003.00% | 8 | 14.29% | 2 | - |
30 Sep, 18 | 7 | 250.00% | 237,168 | -0.46% | 0.01% | 9953833.33% | 7 | 250.00% | - | - |
30 Jun, 18 | 2 | - | 238,268 | - | 0.00% | - | 2 | - | - | - |
Biocept Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Biocept's stock was made by Walsh Robert on Jun 20 2023, selling 806 shares at $30.90 per share (valued at $24.91K).
Biocept Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q4 2022 | 1 | - | - |
Q3 2022 | 5 | - | - |
Q1 2022 | 5 | - | - |
Q4 2021 | - | 3 | - |
Q3 2021 | 13 | 2 | 650.00% |
Q4 2020 | 5 | - | - |
Q3 2020 | 1 | 1 | 100.00% |
Q2 2020 | 6 | 3 | 200.00% |
Q1 2020 | - | 3 | - |
Q2 2019 | 17 | - | - |
Q3 2018 | 1 | - | - |
Q2 2018 | 6 | - | - |
Q1 2018 | 2 | - | - |
Q3 2017 | - | 2 | - |
Q2 2017 | 15 | - | - |
Q1 2017 | 11 | 4 | 275.00% |
Q4 2016 | 22 | 2 | 1100.00% |
Q3 2016 | 5 | - | - |
Q2 2016 | 9 | 1 | 900.00% |
Q1 2016 | 6 | 1 | 600.00% |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Biocept's insiders, as of Q4 2022.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q4 2022 | - | - | - |
Q3 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | - | 3 | - |
Q3 2021 | - | - | - |
Q4 2020 | - | - | - |
Q3 2020 | - | - | - |
Q2 2020 | - | 3 | - |
Q1 2020 | - | - | - |
Q2 2019 | - | - | - |
Q3 2018 | - | - | - |
Q2 2018 | - | - | - |
Q1 2018 | 2 | - | - |
Q3 2017 | - | - | - |
Q2 2017 | - | - | - |
Q1 2017 | - | - | - |
Q4 2016 | 22 | - | - |
Q3 2016 | - | - | - |
Q2 2016 | 8 | - | - |
Q1 2016 | - | - | - |
As of Q4 2022, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Biocept's stocks.
BIOC Ownership FAQ
Who Owns Biocept?
Biocept is owned by institutional shareholders (0.36%), insiders (9.21%), and public (90.43%). The largest institutional shareholder of Biocept is RENAISSANCE TECHNOLOGIES LLC (1.14% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.04% of total shares).
Who are the major institutional shareholders of Biocept?
Biocept's major institutional shareholders are RENAISSANCE TECHNOLOGIES LLC, BLACKROCK INC., GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and HRT FINANCIAL LP. The top five shareholders own together 3.75% of the company's share outstanding.
How many Biocept shareholders are there?
As of Jun 2020, there are 17 institutional shareholders of Biocept.
What percentage of Biocept is owned by RENAISSANCE TECHNOLOGIES LLC?
RENAISSANCE TECHNOLOGIES LLC owns 193.74K shares of Biocept, representing 1.14% of the company's total shares outstanding, valued at $66K (as of Mar 2023).
What percentage of Biocept is owned by BLACKROCK INC?
As of Mar 2023, BLACKROCK INC holds 157.91K shares of Biocept (BIOC), compromising 0.93% of the company, valued at $53.69M.
What percentage of Biocept is owned by GEODE CAPITAL MANAGEMENT, LLC?
GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Biocept. The company owns 134.11K of the company's shares outstanding (worth $45.6M).